News & Events Press Release

XiFin Appoints Craig Kussman as Chief Financial Officer

August 9, 2010

XiFin Inc., the leading provider of revenue cycle management for diagnostic service providers, has appointed Craig Kussman as chief financial officer.

Kussman, former CFO of Breach Security, has extensive financial, strategic and operational experience in technology and biotechnology companies ranging from large public multinational corporations to private start-ups. In his new role, Kussman will be responsible for all company finance and administrative functions, including accounting, financial planning, tax, treasury, legal, intellectual property, investor relations, human resources, purchasing and real estate.

“Craig is a talented finance executive with the business experience of a seasoned operations executive,” stated Lâle White, CEO of XiFin. “His strong combination of skills and experience will be an important addition to XiFin’s executive management team and will support the continuing success of a fast growing, dynamic company like XiFin.”

“XiFin is a visionary company uniquely positioned to capitalize on the growing diagnostic service provider market,” stated Kussman. “With innovative capabilities and an outstanding management team, the company is poised for great success. I look forward to joining the team and helping drive its future growth.”

Kussman is an accomplished executive with more than 25 years of leadership experience and success. He has held a range of executive-level roles at industry-leading companies, most recently serving as CFO and co-CEO at Breach Security, before successfully negotiating its sale to Trustwave.

Additionally, Kussman formerly served as CFO and senior vice president of corporate development for Ascenta Therapeutics, a biopharmaceutical company that develops medicines for the treatment of cancer, leading the company’s $52 million Series C financing, and CFO and CAO of Discovery Partners International, Inc., where he successfully shepherded the merger of Discovery Partners with Infinity Pharmaceuticals, Inc.

Kussman also held executive positions at SYNAVANT Inc., Cognizant Corp., and IMS HEALTH, in addition to various financial and corporate development positions at The Dun & Bradstreet Corporation.

Kussman earned a B.A. cum laude in economics and mathematics from Pomona College and an MBA with distinction in Finance from the Wharton School of Business at the University of Pennsylvania.

Contacts:

Bill Taylor
Vice President, Marketing
XiFin, Inc.
858.436.2995
btaylor@xifin.com

Myla Wagner
Myla Wagner Public Relations
925.736.7515
myla@mylawagnerpr.com

About XiFin

XiFin is an innovative software and services company dedicated to optimizing the economics of healthcare. The company’s cloud-based technology and business intelligence platform links healthcare stakeholders in the delivery and reimbursement of care, optimizing both business and patient outcomes and providing informed, streamlined diagnostic and business decision-making. To learn more, visit www.xifin.com, or follow XiFin on Twitter at www.twitter.com/#!/XiFin.